No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.

BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients sufferin...

Full description

Bibliographic Details
Main Authors: Kristin Stieler, Sarah Schindler, Thorsten Schlomm, Oliver Hohn, Norbert Bannert, Ronald Simon, Sarah Minner, Michael Schindler, Nicole Fischer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3192048?pdf=render
id doaj-c0b6dc4154e74cd897359823f6499842
record_format Article
spelling doaj-c0b6dc4154e74cd897359823f64998422020-11-25T01:00:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2559210.1371/journal.pone.0025592No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.Kristin StielerSarah SchindlerThorsten SchlommOliver HohnNorbert BannertRonald SimonSarah MinnerMichael SchindlerNicole FischerBACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining.http://europepmc.org/articles/PMC3192048?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kristin Stieler
Sarah Schindler
Thorsten Schlomm
Oliver Hohn
Norbert Bannert
Ronald Simon
Sarah Minner
Michael Schindler
Nicole Fischer
spellingShingle Kristin Stieler
Sarah Schindler
Thorsten Schlomm
Oliver Hohn
Norbert Bannert
Ronald Simon
Sarah Minner
Michael Schindler
Nicole Fischer
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
PLoS ONE
author_facet Kristin Stieler
Sarah Schindler
Thorsten Schlomm
Oliver Hohn
Norbert Bannert
Ronald Simon
Sarah Minner
Michael Schindler
Nicole Fischer
author_sort Kristin Stieler
title No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
title_short No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
title_full No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
title_fullStr No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
title_full_unstemmed No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
title_sort no detection of xmrv in blood samples and tissue sections from prostate cancer patients in northern europe.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining.
url http://europepmc.org/articles/PMC3192048?pdf=render
work_keys_str_mv AT kristinstieler nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT sarahschindler nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT thorstenschlomm nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT oliverhohn nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT norbertbannert nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT ronaldsimon nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT sarahminner nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT michaelschindler nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT nicolefischer nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
_version_ 1725214871774035968